M&A · Healthcare · Pharmaceutical Preparations
XOMA Royalty Corp to acquire Mural Oncology plc
Announced Aug 20, 2025 · Closed Dec 5, 2025
Deal value$35M
Premium97.6%To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed$2.04 per share
Transaction
- Acquirer
- XOMA Royalty Corp
- Target
- Mural Oncology plc
- Buyer type
- Strategic
- Offer price per share
- $2.04
- Enterprise value
- —
- Status
- Closed Dec 5, 2025
Deal protections
- Break fee (target pays)
- —
- Reverse fee (buyer pays)
- —
- Go-shop
- No-shop
- Financing
- —
Advisors
- To the acquirer
- Not disclosed
- To the target
- Lucid Capital Markets
Sector context · Healthcare
- Comparable deals
- 95 in the prior 24 months
- Premium
- 97.6% vs. 67.0% sector median
- EV / Adj. EBITDA
- Sector median 14.5x
- Break fee
- Sector median 3.4%
Timeline
- AnnouncedAug 20, 2025
- Proxy filedSep 12, 2025
- Definitive proxySep 23, 2025
- Shareholder voteOct 24, 2025
- ClosedDec 5, 2025